Clinical Trials Logo

Clinical Trial Summary

Eligible subjects will be asked to take a placebo/treatment capsule for a total of 3 days and then participate in a study visit on the fourth day. This study visit will include a medical exam, clinical labs, questionnaires, body composition measurements, and urine and stool collections. Additionally, participants will consume a sugar cocktail to measure their gut permeability, participate in an acute ethanol challenge, and undergo two muscle biopsies. The study will take approximately 3-4 hours and a designated driver will need to drive the participant home. On the fifth day, you will be asked to return to drop of the 24-hour urine collection.


Clinical Trial Description

Interested subjects will be assessed for eligibility and a written informed consent will be obtained. The screening visit will consist of a medical exam, clinical labs (if not available in medical record), and questionnaires. Those who pass the screening will be eligible for a baseline visit (may be combined with screening if appropriate labs are already done). The baseline visit will include collection of blood, urine, and stool samples, body composition measurements, and randomization into either HA35 or placebo groups. Patients will be instructed to take the HA35 or placebo daily in the morning before breakfast 3 days prior to the day 4 visit. Patients will be informed that they will need to have a driver that is known to them for the day 4 visit. In the morning of the day 4 visit, confirmation of a driver will occur prior to starting study procedures. During the day 4 visit, patients will have an acute ethanol challenge where they will need to consume 2mL/kg of vodka in 100mL of juice in under 60 minutes. Muscle biopsies will be collected before and after the challenge and blood will be collected throughout the day. In addition, patients will be given lactulose/mannitol/sucralose/sucrose cocktail to measure gut permeability. The costs of any of these tests/procedures will not be billed to the patient and will be covered by the department. The participant will not be responsible for any costs. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05025865
Study type Interventional
Source The Cleveland Clinic
Contact Srinivasan Dasarathy, MD
Phone 216-318-7010
Email [email protected]
Status Not yet recruiting
Phase Early Phase 1
Start date October 1, 2021
Completion date October 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Recruiting NCT02572700 - Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis
Recruiting NCT01888783 - Two Measures of Tactile Acuity in CRPS Type I Patients N/A
Recruiting NCT03741478 - Intranasal Insulin and Olanzapine Study in Healthy Volunteers Phase 1
Completed NCT02919774 - Pomaglumetad Effects on Glutamate Biomarkers Phase 1
Completed NCT01460394 - Normative Data of Brain Network Activation in Adolescents and Young Adults
Completed NCT00771940 - Peripheral Metabolic Effects of Ghrelin Phase 1
Recruiting NCT02652195 - Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part II Phase 2
Not yet recruiting NCT05046184 - Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets Phase 2
Recruiting NCT04320966 - Neurovascular Complications and White Matter Damage in Acquired Anemias
Completed NCT03134963 - Cerebral Haemodynamic Changes During Cognitive Testing: A fTCD Study
Completed NCT03081546 - Cross-Cultural Use of Performance-Based Functional Assessment in Alzheimer's Disease
Recruiting NCT04085094 - Gender Differences in Renal Functioning and Disease
Completed NCT03520543 - [11C]Yohimbine PET Study of alpha2-AR Phase 1
Completed NCT02134951 - Biomarker Assessment of Glutamatergic Target Engagement Phase 4
Completed NCT01845896 - Influence of High Intensity Exercise on Insulin Resistance, Muscle Contractile Properties, Aerobic Capacity and Body Composition in Multiple Sclerosis N/A
Recruiting NCT01593956 - Influence of Transcranial Direct Current Stimulation on Cortical Plasticity in Concussed Athletes N/A
Completed NCT00977366 - Neurophysiology of Cough Reflex Hypersensitivity N/A
Recruiting NCT03886038 - Subunit Vaccine Against Herpes Zoster in RA Patients Treated With JAK-inhibitors (VACCIMIL-ZOSTER) Phase 4
Recruiting NCT03249233 - Corneal Thickness Changes With Scleral Contact Lenses N/A